Cellectar biosciences, inc. reports earnings results for the third quarter ended september 30, 2019

Cellectar biosciences, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 3.963 million compared to usd 3.087 million a year ago. net loss was usd 3.903 million compared to usd 3.014 million a year ago. basic loss per share from continuing operations was usd 0.42 compared to usd 1.65 a year ago. for the nine months, operating loss was usd 10.794 million compared to usd 9.445 million a year ago. net loss was usd 10.713 million compared to usd 9.411 million a year ago. basic loss per share from continuing operations was usd 1.51 compared to usd 5.29 a year ago.
CLRB Ratings Summary
CLRB Quant Ranking